Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (9): 1356-1363.doi: 10.19982/j.issn.1000-6621.20260278
• Original Articles • Previous Articles Next Articles
Xie Cifu, Song Lixin, Yin Pengliang, Xiong Zi(
)
Received:2026-05-18
Online:2026-09-10
Published:2026-09-08
Contact:
Xiong Zi
E-mail:changshajfk@163.com
Supported by:CLC Number:
Xie Cifu, Song Lixin, Yin Pengliang, Xiong Zi. Evaluation of the intervention effect of an online prize-winning quiz on residents’ core knowledge of pulmonary tuberculosis prevention and control[J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1356-1363. doi: 10.19982/j.issn.1000-6621.20260278
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20260278
| 特征 | 干预组(6638名) | 对照组(6638名) | 合计(13276名) | χ2值 | P值 |
|---|---|---|---|---|---|
| 性别 | 0.290 | 0.590 | |||
| 男性 | 3251(49.0) | 3220(48.5) | 6471(48.7) | ||
| 女性 | 3387(51.0) | 3418(51.5) | 6805(51.3) | ||
| 年龄组(岁) | 1.439 | 0.696 | |||
| <20 | 91(1.4) | 82(1.2) | 173(1.3) | ||
| 20~39 | 5973(90.0) | 6001(90.4) | 11974(90.2) | ||
| 40~59 | 542(8.1) | 518(7.8) | 1060(8.0) | ||
| ≥60 | 32(0.5) | 37(0.6) | 69(0.5) | ||
| 文化程度 | 0.861 | 0.835 | |||
| 小学及以下 | 253(3.8) | 252(3.8) | 505(3.8) | ||
| 初中 | 881(13.3) | 874(13.2) | 1755(13.2) | ||
| 高中 | 1799(27.1) | 1757(26.5) | 3556(26.8) | ||
| 本科及以上 | 3705(55.8) | 3755(56.5) | 7460(56.2) | ||
| 职业 | 6.419 | 0.600 | |||
| 农牧渔船民 | 217(3.3) | 206(3.1) | 423(3.2) | ||
| 机关/事业单位 | 1073(16.2) | 1076(16.2) | 2149(16.2) | ||
| 医务人员 | 1555(23.4) | 1456(21.9) | 3011(22.7) | ||
| 企业 | 2218(33.4) | 2321(35.0) | 4539(34.2) | ||
| 商业/服务业 | 1267(19.1) | 1260(19.0) | 2527(19.0) | ||
| 在校学生 | 175(2.6) | 180(2.7) | 355(2.7) | ||
| 军人 | 8(0.1) | 10(0.2) | 18(0.1) | ||
| 离退休 | 19(0.3) | 22(0.3) | 41(0.3) | ||
| 其他 | 106(1.6) | 107(1.6) | 213(1.6) |
| 特征 | 干预组a | 对照组a | RRb (95%CI)值 | Z值 | P值 | RRRb (95%CI)值 | Z值 | P值 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别 | |||||||||||||||
| 男性 | 88.32 (14220/16100) | 79.62 (12943/16255) | 1.11 (1.10~1.12) | 16.899 | <0.001 | 参照组 | 参照组 | 参照组 | |||||||
| 女性 | 89.98 (15378/17090) | 83.06 (14066/16935) | 1.08 (1.07~1.09) | 14.800 | <0.001 | 0.98 (0.96~0.99) | -3.022 | <0.003 | |||||||
| 年龄组(岁) | |||||||||||||||
| <20 | 86.34 (354/410) | 63.08 (287/455) | 1.37 (1.23~1.53) | 5.613 | <0.001 | 参照组 | 参照组 | 参照组 | |||||||
| 20~39 | 89.48 (26848/30005) | 82.22 (24556/29865) | 1.09 (1.08~1.10) | 20.225 | <0.001 | 0.80 (0.71~0.89) | -4.087 | <0.001 | |||||||
| 40~59 | 86.18 (2232/2590) | 75.20 (2038/2710) | 1.14 (1.11~1.18) | 8.252 | <0.001 | 0.84 (0.75~0.94) | -3.066 | <0.002 | |||||||
| ≥60 | 88.65 (164/185) | 80.00 (128/160) | 1.11 (0.96~1.27) | 1.430 | 0.153 | 0.81 (0.68~0.96) | -2.376 | 0.018 | |||||||
| 文化程度 | |||||||||||||||
| 小学及以下 | 87.06 (1097/1260) | 75.97 (961/1265) | 1.15 (1.09~1.21) | 5.154 | <0.001 | 参照组 | 参照组 | 参照组 | |||||||
| 初中 | 88.38 (3862/4370) | 79.73 (3512/4405) | 1.11 (1.08~1.14) | 7.805 | <0.001 | 0.97 (0.91~1.02) | -1.164 | 0.245 | |||||||
| 高中 | 88.92 (7812/8785) | 81.83 (7361/8995) | 1.09 (1.07~1.11) | 10.715 | <0.001 | 0.95 (0.90~1.00) | -1.870 | 0.061 | |||||||
| 本科及以上 | 89.62 (16827/18775) | 81.92 (15175/18525) | 1.09 (1.08~1.10) | 17.454 | <0.001 | 0.95 (0.91~1.01) | -1.727 | 0.084 | |||||||
| 职业 | |||||||||||||||
| 农牧渔船民 | 86.31 (889/1030) | 79.63 (864/1085) | 1.09 (1.04~1.14) | 3.581 | <0.001 | 参照组 | 参照组 | 参照组 | |||||||
| 机关/事业单位 | 87.40 (4702/5380) | 81.32 (4363/5365) | 1.08 (1.05~1.10) | 7.072 | <0.001 | 0.99 (0.94~1.04) | -0.400 | 0.689 | |||||||
| 医务人员 | 88.65 (6454/7280) | 78.84 (6130/7775) | 1.12 (1.10~1.14) | 11.900 | <0.001 | 1.03 (0.98~1.08) | 1.217 | 0.224 | |||||||
| 企业 | 91.05 (10566/11605) | 83.23 (9230/11090) | 1.09 (1.08~1.11) | 13.806 | <0.001 | 1.01 (0.96~1.06) | 0.263 | 0.793 | |||||||
| 商业/服务业 | 88.78 (5593/6300) | 82.78 (5244/6335) | 1.07 (1.06~1.09) | 8.334 | <0.001 | 0.99 (0.94~1.04) | -0.448 | 0.654 | |||||||
| 在校学生 | 89.56 (806/900) | 78.74 (689/875) | 1.14 (1.09~1.19) | 5.654 | <0.001 | 1.05 (0.98~1.12) | 1.435 | 0.151 | |||||||
| 军人 | 90.00 (45/50) | 90.00 (36/40) | 1.02 (0.81~1.30) | 0.194 | 0.846 | 0.94 (0.74~1.20) | -0.482 | 0.630 | |||||||
| 离退休 | 84.55 (93/110) | 81.05 (77/95) | 1.04 (0.87~1.24) | 0.418 | 0.676 | 0.96 (0.80~1.15) | -0.496 | 0.620 | |||||||
| 其他 | 84.11 (450/535) | 70.94 (376/530) | 1.19 (1.10~1.28) | 4.235 | <0.001 | 1.09 (1.00~1.20) | 1.877 | 0.060 | |||||||
| 合计 | 89.18 (29598/33190) | 81.38 (27009/33190) | 1.10 (1.09~1.10) | 22.499 | <0.001 | - | - | - | |||||||
| 题目 | 干预组 (6638名)a | 对照组 (6638名)a | RRb (95%CI)值 | Z值 | P值 | RRRb (95%CI)值 | Z值 | P值 |
|---|---|---|---|---|---|---|---|---|
| 第1项 | 5034(75.84) | 4612(69.48) | 1.09(1.07~1.11) | 8.226 | <0.001 | 参照组 | 参照组 | 参照组 |
| 第2项 | 5896(88.82) | 5168(77.85) | 1.14(1.12~1.16) | 16.950 | <0.001 | 1.05(1.02~1.07) | 3.651 | <0.001 |
| 第3项 | 6480(97.62) | 6112(92.08) | 1.06(1.05~1.07) | 14.322 | <0.001 | 0.97(0.95~0.99) | -2.653 | 0.008 |
| 第4项 | 5853(88.17) | 5376(80.99) | 1.09(1.07~1.10) | 11.331 | <0.001 | 1.00(0.97~1.02) | -0.212 | 0.832 |
| 第5项 | 6335(95.44) | 5741(86.49) | 1.10(1.09~1.12) | 17.822 | <0.001 | 1.01(0.99~1.03) | 0.972 | 0.331 |
| 项目 | 干预后 (2023年)a | 干预前 (2022年)a | RRb (95%CI)值 | Z值 | P值 | RRRb (95%CI)值 | Z值 | P值 |
|---|---|---|---|---|---|---|---|---|
| 答题次数(次) | ||||||||
| 1 | 93.77 (4032/4300) | 93.07 (4002/4300) | 1.00 (0.99~1.01) | -0.522 | 0.602 | 参照组 | 参照组 | 参照组 |
| 2 | 90.87 (6638/7305) | 90.09 (6581/7305) | 1.04 (1.02~1.05) | 5.962 | <0.001 | 1.04 (1.02~1.05) | 4.782 | <0.001 |
| 3 | 89.17 (5952/6675) | 86.55 (5777/6675) | 1.04 (1.02~1.05) | 5.434 | <0.001 | 1.04 (1.02~1.06) | 4.666 | <0.001 |
| 4 | 88.07 (3985/4525) | 83.36 (3772/4525) | 1.06 (1.04~1.08) | 6.340 | <0.001 | 1.06 (1.04~1.08) | 5.705 | <0.001 |
| ≥5 | 86.58 (8991/10385) | 82.25 (8542/10385) | 1.06 (1.04~1.07) | 7.559 | <0.001 | 1.06 (1.04~1.08) | 6.408 | <0.001 |
| 累计答题时间(min) | ||||||||
| <1 | 91.08 (7687/8440) | 91.33 (7708/8440) | 1.01 (0.99~1.02) | 1.159 | 0.246 | 参照组 | 参照组 | 参照组 |
| 1~<2 | 90.30 (6574/7280) | 87.23 (6350/7280) | 1.01 (1.00~1.02) | 1.547 | 0.122 | 1.00 (0.98~1.02) | 0.136 | 0.892 |
| 2~<3 | 87.88 (5866/6675) | 84.60 (5647/6675) | 1.03 (1.02~1.04) | 4.511 | <0.001 | 1.02 (1.00~1.04) | 2.423 | 0.015 |
| 3~<4 | 88.94 (3442/3870) | 84.16 (3257/3870) | 1.06 (1.04~1.07) | 6.587 | <0.001 | 1.05 (1.03~1.07) | 4.504 | <0.001 |
| ≥4 | 87.06 (6029/6925) | 82.48 (5712/6925) | 1.05 (1.04~1.06) | 8.633 | <0.001 | 1.04 (1.03~1.06) | 4.996 | <0.001 |
| 合计 | 89.18 (29598/33190) | 86.39 (28674/33190) | 1.03 (1.03~1.04) | 10.795 | <0.001 | - | - | - |
| [1] |
Ma N, Zhang L, Chen L, et al. Demographic and socioeconomic disparity in knowledge, attitude, and practice towards tuberculosis in Northwest, China: evidence from multilevel model study[J]. BMC Health Serv Res, 2024, 24(1): 948. doi:10.1186/s12913-024-11336-x.
pmid: 39164685 |
| [2] | 中国防痨协会科普委员会. 加强健康教育健康促进为国家结核病控制服务--中国防痨协会科普委员会记事[J]. 中国健康教育, 2006(8): 564. doi:10.16168/j.cnki.issn.1002-9982.2006.08.032. |
| [3] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011-2015年)的通知[EB]. 国办发〔2011〕53号. 2011-11-17. |
| [4] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知[EB]. 国办发〔2017〕16号. 2017-02-16. |
| [5] | 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 关于印发遏制结核病行动计划(2019-2022年)的通知[EB]. 国卫疾控发〔2019〕41号. 2019-05-31. |
| [6] | 中华人民共和国国家疾病预防控制局, 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 等. 关于印发《全国结核病防治规划(2024-2030年)》的通知[EB]. 国疾控传防发〔2024〕19号. 2024-11-28. |
| [7] | 王静, 夏愔愔, 李涛, 等. 不同地区和年龄组人群接受结核病防治健康教育途径的分析[J]. 中国防痨杂志, 2019, 41(6): 687-694. doi:10.3969/j.issn.1000-6621.2019.06.017. |
| [8] | 张永强, 崔立周, 刘兰瑞, 等. 不同模式预防学校结核病健康教育干预效果比较[J]. 中国学校卫生, 2019, 40(8): 1145-1147. doi:10.16835/j.cnki.1000-9817.2019.08.007. |
| [9] | 刘予东, 严秀丽, 李继海. 泰安市部分在校大学生结核病健康干预活动效果评价[J]. 预防医学论坛, 2011, 17(10): 927-929. doi:10.16406/j.pmt.issn.1672-9153.2011.10.031. |
| [10] | 李运葵, 何金戈, 李婷, 等. 四川省“千村万户”结核病健康促进干预活动效果评估[J]. 预防医学情报杂志, 2016, 32(8): 801-803. |
| [11] |
Walsh K. Tuberculosis Awareness Program: Need for Longer and More Rigorous Follow-up[J]. Int J Prev Med, 2016, 7:4. doi:10.4103/2008-7802.173794.
pmid: 26941905 |
| [12] | 中华人民共和国国家卫生健康委员会. 关于开展“十三五”全国结核病防治规划终期评估的通知[EB]. 国卫办疾控函〔2020〕794号. 2020-08-31. |
| [13] | 赵雁林, 陈明亭. 中国结核病防治工作技术指南[M]. 北京: 人民卫生出版社, 2021. |
| [14] | 田本淳, 孟宪鹏, 吕书红, 等. 2006年全国公众结核病防治知识核心信息知晓情况调查[J]. 中国健康教育, 2008(6): 409-412. doi:10.16168/j.cnki.issn.1002-9982.2008.06.003. |
| [15] | 于兰, 吕青, 夏愔愔, 等. 2010年全国结核病防治核心信息全民知晓率调查分析[J]. 中国防痨杂志, 2013, 35(1): 60-64. doi:10.19982/j.issn.1000-6621.2013.01.016. |
| [16] | Dupont W D, Plummer W D Jr. Power and sample size calculations. A review and computer program[J]. Control Clin Trials, 1990, 11(2): 116-128. doi:10.1016/0197-2456(90)90005-m. |
| [17] | 董龙雨, 王嘉, 倪帅虎, 等. 我国四省大学生结核病防治核心知识、信念和行为现状的调查分析[J]. 中国防痨杂志, 2024, 46(2): 206-212. doi:10.19982/j.issn.1000-6621.20230368. |
| [18] | 安康市卫生健康委员会. 汉阴县创新宣传模式推动结核病防治深入人心[EB/OL]. (2025-03-26) [2026-04-13]. https://wjw.ankang.gov.cn/Content-2804933.html. |
| [19] | 四川新闻网. 巴州区多措并举开展“世界防治结核病日”主题宣传活动[EB/OL]. (2026-03-25) [2026-04-13]. https://bz.newssc.org/system/20260325/003613733.html. |
| [20] | Holst C, Stelzle D, Diep L M, et al. Improving Health Knowledge Through Provision of Free Digital Health Education to Rural Communities in Iringa, Tanzania: Nonrando-mized Intervention Study[J]. J Med Internet Res, 2022, 24(7): e37666. doi:10.2196/37666. |
| [21] |
Ancy A V, Thangaraj P, Hemalatha K, et al. Effect of an e-learning tool on knowledge of recent Revised National Tuberculosis Control Programme guidelines among Medical Interns[J]. J Educ Health Promot, 2020, 9: 257. doi:10.4103/jehp.jehp_744_19.
pmid: 33225001 |
| [22] | 叶子, 杨娟, 郭鹏, 等. 贵阳市大学生结核病防治知信行调查分析[J]. 中国防痨杂志, 2023, 45(3): 265-270. doi:10.19982/j.issn.1000-6621.20220429. |
| [1] | Zhong Leping, Qin Shibing, Sha Wei, Deng Guofang, Lin Minggui. Application and prospect of ultrasound-mediated transdermal drug delivery in adjuvant treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1245-1249. |
| [2] | Huang Huan, Wang Xiaomin, Song Zhe, Li Xuelin, Ding Feng, Wang Jin, Zeng Jianfeng, Wu Haiwu, Zhong Xinguang, Lu Shuihua. Interpretation of the World Health Organization’s Target Product Profiles for Tuberculosis Screening Test Products [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1250-1258. |
| [3] | Ren Feilin, Jin Meihua, Tong Zhaowei, Zheng Pingming. Interpretation of the Group Standard Specifications for the Construction of Tuberculosis Preventive Treatment Clinics in Primary Medical Institutions [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1259-1265. |
| [4] | Bai Yan, Chen Yu, Gao Xusheng, Liang Jianqin, Zeng Yi, Wang Yun, Fan Lin. Analysis of clinical characteristics and factors influencing outcomes in elderly patients with drug-susceptible pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1266-1276. |
| [5] | Li Cheng, Wu Chunli, Xia Fan, Yu Wenduo, Liu Zhenguo, Yi Hengzhong, Wen Xinmin, Tang Zhigang, Huang Sheng, Li Yao, Chen Mengshi, Rong Pengfei. Study on the association between gut microbiota and drug-induced liver injury in patients with drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1277-1289. |
| [6] | Xu Chaoyan, Wei Jiaojiao, Li Shanshan, Yao Lin, Li Ling, Gao Mengqiu. Construction and clinical evaluation of an early diagnostic model for Mycobacterium intracellulare pulmonary disease [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1290-1299. |
| [7] | Ma Liang, Ilyar Batyr, Gu Fuding, Tang Wei, Zhou Wenzheng, Dilixiati Abulizi, Mierzhati Aisha, Qin Wei. Retrospective analysis of 21 cases of advanced knee tuberculosis treated with one-stage radical debridement and total knee arthroplasty [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1300-1306. |
| [8] | Zhang Aihua, Xu Meng, Yang Yuying, Su Shuang, Song Lei, Ma Dandan, Wei Suxia, Cheng Junwei, Fu Chaohong. Analysis of the incidence of anemia and related risk factors in 878 AIDS patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1307-1314. |
| [9] | Xue Yunlian, Li Sijie, Jiang Xue, Liu Guihao, Wu Huizhong, Wang Tingting, Zhou Zhanqi, Ji Lianrong, Wang Jiawen, Wu Xinghua, Wu Yue, Zhou Lin. Global, regional, and national burdens of tuberculosis attributable to smoking from 1990 to 2021 [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1315-1323. |
| [10] | Huang Liping, Gu Wenju, Bao Peiyu, Shen Jiayi, Song Yanzheng, Zhang Lin. The current status and influencing factors of preoperative anxiety in patients with cervical lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1324-1330. |
| [11] | Zhao Yuchuan, Chen Yanmei, Zhang Chenchen, Yu Meiling, Peng Kehao, Xu Liuyue, Liang Hongdi, Chen Xunxun. Research on performance comparison and selection strategies of digital PCR platforms for tuberculosis detection [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1331-1337. |
| [12] | Gulijiamali Rexiding, Gulina Badeerhan, Wang Mingzhe, Paziliya Aini, Yipar Aihaiti, Wang le, Liu Nianqiang, Dong Xiao, Wang Senlu. Predictive value of ARIMA model and Holt-Winters exponential smoothing method for pulmonary tuberculosis incidence in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1338-1345. |
| [13] | Zhou Ran, Deng Jing, Chen Haiyi, Zhang Ting, Zheng Denghu. Risk prediction of catastrophic household cost among patients with rifampicin-susceptible pulmonary tuberculosis in Chongqing Municipality [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1364-1374. |
| [14] | Huang Quanjiang, Huang Minying, Cui Zhezhe. Quality evaluation of tuberculosis prevention and control work in Guangxi based on Entropy Weight-TOPSIS and RSR method [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1375-1385. |
| [15] | Chen Anni, Meng Yujie, Li Tao, Zheng Huan, Wang Songwang. Trend of pulmonary tuberculosis reported incidence in four core megacities of China from 2015 to 2024: a population-based study using Joinpoint regression model [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1386-1393. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.